Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95 % CI | p value | HR | 95 % CI | p value | |
Remission duration | 0.446 | 0.276–0.721 | 0.001* | 0.390 | 0.233–0.653 | <0.001* |
Age | 1.513 | 0.925–2.474 | 0.099 | |||
Gender | 0.909 | 0.510–1.619 | 0.745 | |||
2010UICC/AJCC T staging | 1.134 | 0.875–1.469 | 0.341 | |||
2010UICC/AJCC N staging | 1.047 | 0.725–1.513 | 0.805 | |||
2010UICC/AJCC stage | 1.085 | 0.770–1.530 | 0.640 | |||
Treatment modality | 0.303 | 0.120–0.766 | 0.012* | 0.344 | 0.133–0.885 | 0.027* |
Recurrence | 1.210 | 0.657–2.227 | 0.541 | |||
Metastatic site | 7.341 | 1.610–33.479 | 0.010* | 5.972 | 1.292–27.609 | 0.022* |